Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

58.73 +0.13 (+0.22%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catalent Inc

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022
From Catalent, Inc.
Via Business Wire
Catalent, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Catalent, Inc.
Via Business Wire
A Look Into Catalent's Price Over Earnings
In the current session, Catalent Inc. (NYSE:CTLT) is trading at $128.13, after a 0.1% increase. Over the past month, the stock increased by 0.34%, and in the past... 
Via Benzinga
Catalent, Inc. to Present at the Stephens Annual Investment Conference
From Catalent, Inc.
Via Business Wire
Expert Ratings For Catalent
Analysts have provided the following ratings for Catalent (NYSE:CTLT) within ... 
Via Benzinga
Where Catalent Stands With Analysts
Analysts have provided the following ratings for Catalent (NYSE:CTLT) within ... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021
Upgrades According to B of A Securities, the prior rating for Generac Holdings Inc (NYSE: 
Via Benzinga
Catalent, inc (CTLT) Q1 2022 Earnings Call Transcript
CTLT earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... 
Via Benzinga
Exposures COVID-19
Catalent, Inc. Reports First Quarter Fiscal 2022 Results
From Catalent, Inc.
Via Business Wire
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Catalent, Inc. Announces First Quarter Fiscal Year 2022 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
Chair And CEO Of Catalent Trades $22M In Company Stock
John Chiminski, Chair And CEO at Catalent (NYSE:CTLT), made a large buy and sell of company shares on October 1, according to a new SEC filing. What Happened: A Form 4 filing from... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2030
From Catalent, Inc.
Via Business Wire
Catalent Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes Due 2030
From Catalent, Inc.
Via Business Wire
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Catalent, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
From Catalent, Inc.
Via Business Wire
Market Rally At Highs, Led By Apple, Growth Stocks: Weekly Review
The market rally hit fresh highs this week, with growth leading the way. 
Via Investor's Business Daily
Topics Bonds Economy Stocks
Exposures Debt Markets Fossil Fuels Interest Rates
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
10 Biggest Price Target Changes For Tuesday
Morgan Stanley raised Lowe's Companies, Inc. (NYSE:L... 
Via Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
Catalent, inc (CTLT) Q4 2021 Earnings Call Transcript
CTLT earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Mid-Afternoon Market Update: Affirm Shares Jump Following News Of Amazon Partnership; Adtran Shares Drop
Toward the end of trading Monday, the Dow traded up 0.02% to 35,462.17 while the NASDAQ rose 1.02% to 15,283.07. The S&P also rose, gaining 0.59% to 4,535.90. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
Mid-Day Market Update: Nasdaq Jumps Over 100 Points; Astra Space Shares Plunge
Midway through trading Monday, the Dow traded up 0.10% to 35,490.10 while the NASDAQ rose 0.85% to 15,258.38. The S&P also rose, gaining 0.59% to 4,536.02. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... 
Via Benzinga
Exposures COVID-19 Product Safety
Mid-Morning Market Update: Markets Mixed; Catalent To Acquire Bettera
Following the market opening Monday, the Dow traded down 0.13% to 35,408.32 while the NASDAQ rose 0.61% to 15,221.76. The S&P also rose, gaining 0.32% to 4,523.75. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Catalent Makes Strategic Move For Consumer Health Business With Bettera Deal
Catalent Inc (NYSE: CTLT) has reported Q4 sales of $1.19 billion, +25% Y/Y as reported, or 22% in constant currency, edging out analysts' average expectation... 
Via Benzinga
Catalent to Extend Leadership in Rapidly Growing Nutraceuticals Market with Proposed $1 Billion Acquisition of Bettera, a Leading Gummies Manufacturer
From Catalent, Inc.
Via Business Wire
Catalent, Inc. Reports Fourth Quarter Fiscal 2021 Results
From Catalent, Inc.
Via Business Wire
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.